The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALBIREO PHARMA INC | COM | 01345P106 | 5,369 | 162,905 | SH | SOLE | 162,905 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 5,981 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 166 | 56,650 | SH | SOLE | 56,650 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 11,231 | 244,050 | SH | SOLE | 244,050 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 4,441 | 119,578 | SH | SOLE | 119,578 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 2,828 | 76,741 | SH | SOLE | 76,741 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 9,351 | 96,428 | SH | SOLE | 96,428 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 2,550 | 236,558 | SH | SOLE | 236,558 | 0 | 0 | ||
| CENTENE CORP DEL | COM | 15135B101 | 2,878 | 19,875 | SH | SOLE | 19,875 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 1,430 | 324,902 | SH | SOLE | 324,902 | 0 | 0 | ||
| CIGNA CORPORATION | COM | 125509109 | 6,088 | 29,236 | SH | SOLE | 29,236 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 4,097 | 341,457 | SH | SOLE | 341,457 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 2,578 | 138,460 | SH | SOLE | 138,460 | 0 | 0 | ||
| HANGER INC | COM NEW | 41043F208 | 24,988 | 1,199,602 | SH | SOLE | 1,199,602 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 7,555 | 1,337,191 | SH | SOLE | 1,337,191 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 8,047 | 715,317 | SH | SOLE | 715,317 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,120 | 52,331 | SH | SOLE | 52,331 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 4,439 | 253,631 | SH | SOLE | 253,631 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 9,808 | 457,475 | SH | SOLE | 457,475 | 0 | 0 | ||
| MEIRAGTX HOLDINGS PLC | COM | G59665102 | 527 | 38,746 | SH | SOLE | 38,746 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 1,314 | 444,068 | SH | SOLE | 444,068 | 0 | 0 | ||
| OVASCIENCE INC | COM | 69014Q101 | 1,116 | 1,529,700 | SH | SOLE | 1,529,700 | 0 | 0 | ||
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 9,307 | 1,661,940 | SH | SOLE | 1,661,940 | 0 | 0 | ||
| PROVIDENCE SVC CORP | COM | 743815102 | 5,733 | 85,217 | SH | SOLE | 85,217 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 6,553 | 80,155 | SH | SOLE | 80,155 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299956 | 2,939 | 102,300 | SH | Put | SOLE | 102,300 | 0 | 0 | |
| SHIRE PLC | SPONSORED ADR | 82481R106 | 4,242 | 23,400 | SH | SOLE | 23,400 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 4,624 | 2,720,089 | SH | SOLE | 2,720,089 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 2,056 | 423,846 | SH | SOLE | 423,846 | 0 | 0 | ||
| TELIGENT INC NEW | COM | 87960W104 | 12,801 | 3,240,761 | SH | SOLE | 3,240,761 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 4,780 | 274,410 | SH | SOLE | 274,410 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 8,405 | 63,930 | SH | SOLE | 63,930 | 0 | 0 | ||